Irina Aleksandrovna Goroshinskaya

Irina Aleksandrovna Goroshinskaya

Auto-generated profile, based on publicly available information

Irina Aleksandrovna Goroshinskaya

National Medical Research Centre for Oncology Rostov-on-Don, Russian Federation

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
IGI. A. Goroshinskaya
I. A. Goroshinskaya
ESE. I. Surikova
E. I. Surikova
EFE. M. Frantsiyants
E. M. Frantsiyants
INI. V. Neskubina
I. V. Neskubina
LNL. A. Nemashkalova
L. A. Nemashkalova
AMA. A. Maslov
A. A. Maslov
Редокс формы глутатиона при злокачественном поражении желудка разной степени агрессивности

11 May 2023 in South Russian Journal of Cancer
Verified
Journal Article
Open access
PDF file
NPN. N. Popova
N. N. Popova
IGI. A. Goroshinskaya
I. A. Goroshinskaya
ASA. I. Shikhlyarova
A. I. Shikhlyarova
DRD. A. Rozenko
D. A. Rozenko
AMA. P. Menshenina
A. P. Menshenina
SCS. A. Chekmezova
S. A. Chekmezova
Purpose of the study. To analyse free radical oxidation and antioxidant defense in patients diagnosed with early cervical cancer (CC) before and after radical surgical treatment.Patients and methods. Levels of diene conjugates, malondialdehyde (MDA), superoxide dismutase (SOD), catalase, glutathione, glutathione- dependent enzymes, vitamins A and E were determined in 74 women under the age of 45 (48 patients those who were at the stage of surgical treatment with a diagnosis of CC at the National Medical Research Center of Oncology in the period 2017–2020 and 26 healthy women).Results. Patients with early CC showed significant changes in the intensity of lipid peroxidation processes and in antioxidant defense: elevate levels of MDA and diene conjugates, initial decline in the activity of SOD and catalase, low levels of vitamins A and E. These results complete the understanding of the processes occurring in the body of an oncological patient at the initial stage of tumor formation, which does not yet have an obvious clinical manifestation. After total removal of the ovaries, most of the indicators characterizing the enzymatic link of the antioxidant system tend to normalize, while the violation of the content of vitamins E and A (related to the non-enzymatic link of the antioxidant system) worsens.Conclusions. Desynchronization of free radical oxidation processes with multidirectional changes in oxidation and antioxidation in patients with early CC at the stage of radical surgical treatment should be considered from the position of hormone‑ reducing surgery and a resulting complex of changes in the organs and systems of women with cancer.

1 March 2015 in Nanotechnologies in Russia
Verified
Journal Article
Closed access
PDF file
VBVladimir Borodulin
Vladimir Borodulin
IGI. A. Goroshinskaya
I. A. Goroshinskaya
PKP. S. Kachesova
P. S. Kachesova
IBI. V. Babushkina
I. V. Babushkina
OPO. E. Polozhentsev
O. E. Polozhentsev
YCYu. S. Chesovskih
Yu. S. Chesovskih
The biological effect of iron nanoparticles with a size of 20–40nm obtained by the plasmochemical method are studied. An antibacterial effect on antibiotic resistant strains of Pseudomonas aeruginosa...

1 January 2020 in Современные проблемы науки и образования (Modern Problems of Science and Education)
Verified
Journal Article
Open access
IGI.A. Goroshinskaya
I.A. Goroshinskaya
EFE.M. Frantsiyants
E.M. Frantsiyants
VAV.I. Aleynov
V.I. Aleynov
LNL.A. Nemashkalova
L.A. Nemashkalova
NCN.D. Cheryarina
N.D. Cheryarina
OKOleg Ivanovich Kit
Oleg Ivanovich Kit

1 January 2022 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
STS.V. Tumanyan
S.V. Tumanyan
MVM.A. Vereshchak
M.A. Vereshchak
IGI.A. Goroshinskaya
I.A. Goroshinskaya
AMA.P. Menshenina
A.P. Menshenina
DRD.A. Rozenko
D.A. Rozenko
SCS.A. Chekmezova
S.A. Chekmezova
ЦЕЛЬ ИССЛЕДОВАНИЯ Анализ влияния вариантов мультимодального анестезиологического обеспечения на функциональное состояние печени и уровень маркеров эндогенной интоксикации (ЭИ) у пациентов, оперированных по поводу онкогинекологических заболеваний после неоадъювантной химиотерапии (НАХТ). МАТЕРИАЛ И МЕТОДЫ Проведено проспективное рандомизированное исследование эффективности различных вариантов мультимодальной анестезии (ММА) у 122 пациентов в возрасте 36—76 лет после НАХТ. Больные разделены на 2 группы. Пациентам 1-й группы (n=59) выполняли анестезию севофлураном с эпидуральной аналгезией, пациентам 2-й группы (n=63) интраоперационно проводили ТАР-блок. Аналгезию поддерживали инфузией лидокаина, сернокислой магнезией, фентанилом, нестероидными противовоспалительными препаратами. Группы разделены на подгруппы — А и Б. У пациентов подгрупп А обеих групп в составе ММА с целью уменьшения проявлений ЭИ и гепатопатии использовали Ремаксол за 2 ч до хирургического вмешательства, интраоперационно и в первые трое суток. У пациентов подгрупп Б использование Ремаксола не предполагалось. Изучены биохимические показатели: общая (ОКА) и эффективная концентрация (ЭКА) альбумина, связывающая способность альбумина, содержание С-реактивного белка и ферментов печени. РЕЗУЛЬТАТЫ У всех пациентов преморбидный фон характеризовался ЭИ, интенсификацией системного воспалительного ответа, гепатопатией. На этапах исследования динамика изучаемых показателей зависела от вариантов ММА. У пациентов, получавших Ремаксол, наблюдалось повышение ЭКА и ОКА, свидетельствующее о значительном снижении ЭИ. Уменьшался расход опиоидных аналгетиков. ЗАКЛЮЧЕНИЕ Включение в состав мультимодальной анестезии препарата Ремаксол обеспечивает уменьшение выраженности проявлений гепатопатии и эндогенной интоксикации, снижение расхода опиоидсодержащих аналгетиков в интра- и послеоперационном периодах.

26 March 2023 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
AMA. P. Menshenina
A. P. Menshenina
IGI. A. Goroshinskaya
I. A. Goroshinskaya
EFE. M. Frantsiyants
E. M. Frantsiyants
TMT. I. Moiseenko
T. I. Moiseenko
EVE. V. Verenikina
E. V. Verenikina
LNL. A. Nemashkalova
L. A. Nemashkalova
Purpose of the study. The purpose of the study was to evaluate the dynamics of parameters of malondialdehyde (MDA), reduced glutathione and antioxidant enzyme activity in patients with advanced cervical cancer (CC) receiving anticancer treatment with dendritic cell vaccine (DCV).Patients and methods. Levels of malondialdehyde (MDA), reduced glutathione and antioxidant enzyme activity were studied in 27 patients aged 27–65 years with advanced primary and recurrent CC receiving chemotherapy (CT) with DCV or DCV as monotherapy at a dose of 10 million cells intradermally once a week. The same indices were studied in 20 healthy women from the comparison group.Results. The majority of patients showed the initial increase of MDA: in blood plasma by an average of 66.7 %, in red blood cells – statistically insignificant. After CT, MDA levels were elevated respectively in primary and recurrent patients in erythrocytes by 85.6 % and 96.4 % compared to donors, and by 53.9 % and 33.7 % compared to the initial values; the levels in plasma were elevated by 79.8 % and 57.1 % compared to donors. After 5–7 DCVs in combination with CT, MDA levels in erythrocytes and in blood plasma were similar to the donor values. MDA in erythrocytes of patients receiving DCV without CT decreased by 36 % compared to initial values. Oxidase activity of ceruloplasmin, initially increased by 34.2–57.1 %, normalized after DCV. Superoxide dismutase activity decreased by 16.7–27.3 % after 4–6 DCVs and normalized after 7 DCVs. Catalase activity, initially reduced by more than 40 %, remained 20–38 % lower than the norm at all stages of DCV. In this setting, hydrogen peroxide was probably inactivated by glutathione peroxidase whose activity was increased at all stages of treatment and decreased only when MDA was normalized after 7 DCVs.Conclusion. Administration of 5–7 DCVs in combination with CT or as monotherapy to patients with advanced CC normalizes parameters of free radical oxidation and antioxidant system of the blood.